Bevacizumab-alone Maintenance Treatment Progression
1 clinical trials · Condition
◉ Watch Bevacizumab-alone Maintenance Treatment Progression
| Record | Firm | Date |
|---|---|---|
| Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB in Advanced HER-2 Negative Breast Cancer (NCT02802098) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2016-05-01 |
Track Bevacizumab-alone Maintenance Treatment Progression automatically
Every clearance here is in the API, with alerts when new ones post.